A. Petrolati

13C‐methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation

G. Tisone, D. Festi, M. Angelico, 2003, Alimentary pharmacology & therapeutics.

Cutaneous Metastatic Crohn's Disease Responsive to Infliximab

N. Altavilla, R. Cipolla, S. Nasoni, 2009, The American Journal of Gastroenterology.

Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV‐related cirrhosis

G. Tisone, C. Casciani, M. Trinito, 2002 .

Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV‐related cirrhosis

G. Tisone, C. Casciani, M. Trinito, 2001, Hepatology.

778 Extended double-dosage HBV vaccination after liver transplantation is ineffective, even without lamivudine and prior HBIG wash-out

G. Tisone, C. Telesca, I. Lenci, 2003 .

A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.

M. Strazzabosco, M. Merli, G. Tisone, 2007, Journal of hepatology.

Correlation Between Liver Fibrosis and Inflammation in Patients Transplanted for HCV Liver Disease

M. Carbone, G. Tisone, L. Baiocchi, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Breath tests with stable isotopes: have they a role in liver transplantation?

E. Vitacolonna, A. Colecchia, D. Festi, 2004, European review for medical and pharmacological sciences.

Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location.

R. Stasi, E. di Stasio, Claudio M Pacella, 2012, AJR. American journal of roentgenology.

Analysis of factors predicting survival in patients with hepatocellular carcinoma treated with percutaneous laser ablation.

Giancarlo Bizzarri, Antonio Bianchini, Dario Valle, 2006, Journal of hepatology.

100 Peginterferon alfa-2A (40KD) with or without ribavirin in the treatment of recurrent hepatitis C after liver transplantation: Preliminary report of a randomized study

M. Strazzabosco, P. Angeli, M. Merli, 2004 .